Literature DB >> 1655749

The cAMP-regulated enhancer-binding protein ATF-1 activates transcription in response to cAMP-dependent protein kinase A.

R P Rehfuss1, K M Walton, M M Loriaux, R H Goodman.   

Abstract

Many promoters respond transcriptionally to elevated levels of cAMP through the cAMP-responsive enhancer (CRE). Several proteins have been characterized which bind to the CRE and presumably modulate CRE-dependent transcription. Of these CRE-binding proteins, only CREB has been shown to be activated by cAMP-dependent protein kinase A (PKA), and as such, CREB represents the only basis for our understanding of cAMP-regulated transcriptional activity. In this report, we describe the complete cDNA sequence of another CRE-binding protein, ATF-1. This protein contains a consensus phosphorylation site for PKA and shares extensive homology with CREB in the region surrounding and carboxyl-terminal to the PKA site. ATF-1 does not contain sequences homologous to the glutamine-rich amino-terminal domain found in CREB, however. ATF-1, like CREB, is expressed in a wide variety of cell types, and ATF-1 is capable of dimerizing with CREB. Both ATF-1 homodimers and ATF-1/CREB heterodimers bind to the CRE but not to the related phorbol ester response element. ATF-1 is as active as CREB in its ability to mediate the transcriptional effects of PKA, and, because ATF-1 has a smaller effect on basal expression, it is actually more responsive than CREB to cAMP. These findings indicate that CREB is not unique in its ability to mediate cAMP-dependent transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655749

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

Review 2.  Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB.

Authors:  P Haus-Seuffert; M Meisterernst
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

3.  Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation.

Authors:  L K Chang; S T Liu
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

4.  DNA damage response of cloned DNA beta-polymerase promoter is blocked in mutant cell lines deficient in protein kinase A.

Authors:  E W Englander; S H Wilson
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

5.  Identification of proteins that interact with CREB during differentiation of F9 embryonal carcinoma cells.

Authors:  N Masson; H C Hurst; K A Lee
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

6.  Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter.

Authors:  P Liu; S Liu; S H Speck
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection.

Authors:  J A Kerry; M A Priddy; T L Staley; T R Jones; R M Stenberg
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  Mechanism of cAMP regulation of renin gene transcription by proximal promoter.

Authors:  K Tamura; S Umemura; S Yamaguchi; T Iwamoto; S Kobayashi; A Fukamizu; K Murakami; M Ishii
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 9.  Transcriptional regulation by cAMP and Ca2+ links the Na+/Ca2+ exchanger 3 to memory and sensory pathways.

Authors:  Nadia Gabellini
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

10.  Transcriptional induction of the human renin gene by cyclic AMP requires cyclic AMP response element-binding protein (CREB) and a factor binding a pituitary-specific trans-acting factor (Pit-1) motif.

Authors:  S Germain; T Konoshita; J Philippe; P Corvol; F Pinet
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.